Alfortville, France

Valérie Polard

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Alfortville, FR (2009 - 2011)
  • Plabennec, FR (2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Valérie Polard: Innovator in Cancer Treatment

Introduction

Valérie Polard is a notable inventor based in Plabennec, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic approaches. His work focuses on improving the efficacy and safety of cancer therapies, particularly for hepatocellular carcinoma.

Latest Patents

Valérie Polard holds a patent for "Nanoparticles loaded with chemotherapeutic antitumoral drug." This invention relates to new therapeutic strategies for treating cancer, specifically targeting hepatocellular carcinoma. The patented technology involves the administration of nanoparticles loaded with a chemotherapeutic agent via intravenous infusion for at least two hours. This method aims to minimize toxicological side effects and enhance the benefit/risk ratio of cancer treatment.

Career Highlights

Throughout his career, Valérie Polard has worked with various companies, including Onxeo S.A. and Onxeo. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Valérie has collaborated with several professionals in the field, including Emilia Pisani and Sophie Lebel-Binay. These partnerships have played a crucial role in the advancement of his research and the successful development of his patented technologies.

Conclusion

Valérie Polard is a pioneering inventor whose work in cancer treatment has the potential to significantly improve patient outcomes. His innovative approach to using nanoparticles in chemotherapy represents a promising advancement in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…